FDA Orange Book · active-ingredient family
Calcium gluconate
Calcium gluconate: 2 brands, 8 generics; first approved Jun 15, 2017; generic available.
Generic availableHas discontinued products
Generic status & protection
Generic available: 8 ANDA applications approved.
Earliest patent expiry
Brands (NDA)
2
Generics (ANDA)
8
Listed patents
2
Next patent expiry
Jul 25, 2037
in 10 yr 11 mo
Brand (NDA) products
Originator applications
- CALCIUM GLUCONATERLDRSHQ SPCLT PHARMANDA 21090620254 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1GM/50ML (20MG/ML) SOLUTION INTRAVENOUS Rx - 2GM/100ML (20MG/ML) SOLUTION INTRAVENOUS Rx - 1GM/100ML (10MG/ML) SOLUTION INTRAVENOUS Rx - 10GM/100ML (100MG/ML) SOLUTION INTRAVENOUS Rx - - CALCIUM GLUCONATERLDRSFRESENIUS KABI USANDA 20841820175 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1GM/10ML (100MG/ML) SOLUTION INTRAVENOUS Rx AP 5GM/50ML (100MG/ML) SOLUTION INTRAVENOUS Rx AP 10GM/100ML (100MG/ML) SOLUTION INTRAVENOUS Rx AP 1GM/50ML (20MG/ML) SOLUTION INTRAVENOUS Discontinued - 2GM/100ML (20MG/ML) SOLUTION INTRAVENOUS Discontinued -
Generic (ANDA) products (8)
Abbreviated applications
- MILLA PHARMSANDA 21903720262 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1GM/50ML (20MG/ML) SOLUTION INTRAVENOUS Rx AP 2GM/100ML (20MG/ML) SOLUTION INTRAVENOUS Rx AP - CALCIUM GLUCONATECAPLINANDA 21884020263 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1GM/10ML (100MG/ML) SOLUTION INTRAVENOUS Rx AP 5GM/50ML (100MG/ML) SOLUTION INTRAVENOUS Rx AP 10GM/100ML (100MG/ML) SOLUTION INTRAVENOUS Rx AP - SAGENTANDA 21961920252 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1GM/50ML (20MG/ML) SOLUTION INTRAVENOUS Rx AP 2GM/100ML (20MG/ML) SOLUTION INTRAVENOUS Rx AP - CALCIUM GLUCONATEAMNEALANDA 21661120243 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1GM/10ML (100MG/ML) SOLUTION INTRAVENOUS Rx AP 5GM/50ML (100MG/ML) SOLUTION INTRAVENOUS Rx AP 10GM/100ML (100MG/ML) SOLUTION INTRAVENOUS Rx AP - CALCIUM GLUCONATESOMERSETANDA 21768920232 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 5GM/50ML (100MG/ML) SOLUTION INTRAVENOUS Rx AP 10GM/100ML (100MG/ML) SOLUTION INTRAVENOUS Rx AP - AMNEALANDA 21717420232 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1GM/50ML (20MG/ML) SOLUTION INTRAVENOUS Rx AP 2GM/100ML (20MG/ML) SOLUTION INTRAVENOUS Rx AP - CALCIUM GLUCONATEB BRAUN MEDICALANDA 2165412023
Approved strengths under this FDA application. Strength Dosage form Route Status TE 10GM/100ML (100MG/ML) SOLUTION INTRAVENOUS Rx AP - CALCIUM GLUCONATENIVAGENANDA 21307120223 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1GM/10ML (100MG/ML) SOLUTION INTRAVENOUS Rx AP 5GM/50ML (100MG/ML) SOLUTION INTRAVENOUS Rx AP 10GM/100ML (100MG/ML) SOLUTION INTRAVENOUS Rx AP
Patent & exclusivity timeline
Protection horizon
Patent expiryExclusivity endToday
Listed patents
Orange Book patent file
| Patent | Expires | In | Type |
|---|---|---|---|
| 10130646 | in 10 yr 11 mo | Product | |
| 10342813 | in 10 yr 11 mo | Product |
Approval history
FDA approval span
First approval
9 yr 6 mo ago
Most recent approval
2 mo ago
Approvals span 2017–2026 across 10 FDA applications.
Brand (NDA) 220%
Generic (ANDA) 880%
Calcium gluconate: frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
Assyro Intelligence
Ask anything about Calcium gluconate
Cited answers from FDA, EMA, Health Canada, PubMed and ClinicalTrials.gov, in seconds. Free, no sign-up.
Evaluating for a team? Book a demo